Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: A phase II Eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)

Madhur K. Garg, Fengmin Zhao, Joseph A. Sparano*, Joel Palefsky, Richard Whittington, Edith P. Mitchell, Mary F. Mulcahy, Karin I. Armstrong, Nassim H. Nabbout, Shalom Kalnicki, Bassel F. El-Rayes, Adedayo A. Onitilo, Daniel J. Moriarty, Thomas J. Fitzgerald, Al B. Benson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: A phase II Eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)'. Together they form a unique fingerprint.

Medicine & Life Sciences